Last reviewed · How we verify

NCT03148678

Scrutinizing and Promoting Mindfulness Via New Technologies

Completed NA Last updated 16 December 2024
What this trial tests

NA trial testing Mindfulness in Mindfulness in 84 participants. Completed in 5 March 2019.

Timeline
31 March 2017
Primary endpoint
5 March 2019
5 March 2019

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingdouble
Primary purposebasic science
Enrollment84
Start date31 March 2017
Primary completion5 March 2019
Estimated completion5 March 2019
Sites2 locations across Switzerland, South Korea

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

Adults 18 to 65, male only, with Mindfulness or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of the outlined study is to scrutinize and to promote mindfulness via new technologies using a combination of smartphone-based assessment and micro-interventions, fMRI and real-time fMRI-neurofeedback.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Spectral dynamic causal modeling of mindfulness, mind-wandering, and resting-state in the triple network using fMRI.
    Kim HC, Lee JH. · · 2022 · cited 4× · PMID 35287148 · DOI 10.1097/wnr.0000000000001772

Verify or expand the search:

Other trials of Mindfulness

Trials testing the same drug.

Other recruiting trials for Mindfulness

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03148678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing